Eiger Biopharmaceuticals, Inc. (EIGR) Stockholder News: Lead Plaintiff Deadline is Fast Approaching; Contact Robbins LLP for More Information
December 12, 2022 17:06 ET
|
Robbins LLP
SAN DIEGO, Dec. 12, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise...
Eiger Biopharmaceuticals, Inc. (EIGR) Equity Notice: Contact Robbins LLP if You Incurred Significant Damages From Your Investment in Eiger Biopharmaceuticals, Inc.
November 28, 2022 17:00 ET
|
Robbins LLP
SAN DIEGO, Nov. 28, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise...
Eiger Biopharmaceutials, Inc. (EIGR) Shareholder Update: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Eiger Biopharmaceutials, Inc.
November 17, 2022 13:34 ET
|
Robbins LLP
SAN DIEGO, Nov. 17, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise...